Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development

Area of Science:

• Cardiovascular Disease Research
• Global Health Equity

Background:

• Stroke and cardiovascular disease (CVD) prevention and treatment research predominantly targets high-income countries (HIC).
• The majority of global stroke and CVD mortality occurs in low- and middle-income countries (LMIC), with projections indicating further increases.

Purpose of the Study:

• To highlight the critical need for developing and implementing effective stroke and CVD strategies in LMIC.
• To advocate for global health equity in cardiovascular disease management.

Main Methods:

• Review of existing strategies for stroke and CVD treatment in HIC.
• Analysis of current initiatives to involve LMIC in global clinical trials.
• Examination of pharmaceutical pricing models for LMIC.

Main Results:

• Established, cost-effective stroke and CVD treatment strategies exist in HIC.
• Inclusion of LMIC in clinical trials enhances global relevance and affordability.
• Pharmaceutical companies are encouraged to offer affordable medications for stroke prevention in LMIC.

Conclusions:

• Cost-effective drug development and affordable pricing are crucial for managing the escalating stroke burden in LMIC.
• Protecting intellectual property rights while ensuring affordability is key to preventing unmanageable increases in stroke cases globally.